HH signaling has a key role in maintaining stemness and promoting chemoresistance across multiple cancer types [39–41]; in particular, given the established role in conferring resistance to 5-FU treatment, we decided to focus our subsequent analyses on clarifying the relationship between HH, PHGDH and therapy resistance. Here, PHGDH is linked to cancer.